Table 1

Baseline demographics according to GRACE risk score (n=341)

Clinical characteristicsLow GRACE score group (n=229)Intermediate-high GRACE score group (n=112)P value
Age (years), mean±SD57.4±9.168.3±8.7<0.001
Gender, (%)
Male135 (59.0)65 (58.0)0.907
Time from symptoms onset to fibrinolytic therapy, median (hours) (IQR: 25th, 75th percentile)2.8 (IQR: 2,4.0)2.9 (IQR: 2,4.6)0.571
Time from fibrinolysis to coronary intervention, median (days) (IQR: 25th, 75th percentile)5.5 (IQR:2.9,9.1)6.2 (IQR: 3.1,10.3)0.625
LVEF (%)54.5±11.153.1±12.90.306
GRACE score, mean±SD100.1±17.7142.2±14.3<0.001
Medical conditions, n (%)
 Smoking145 (63.8)62 (55.4)0.151
 Hypertension103 (45.0)57 (50.9)0.355
 Diabetes48 (20.9)17 (15.2)0.241
 Dyslipidaemia104 (45.8)32 (28.6)0.002
 Smoking145 (63.8)62 (55.4)0.155
 Chronic kidney disease11 (4.8)10 (9.0)0.151
 Prior PCI2 (0.9)6 (5.4)0.017
Medications, n (%)
 Aspirin229 (100)112 (100)NA
 Clopidogrel220 (96.1)107 (95.5)0.779
 Low molecular weight heparin209 (91.7)103 (92.0)0.554
 ACEI/ARB167 (72.9)88 (78.6)0.260
 Beta-blocker144 (62.8)72 (64.2)0.801
  • Data presented as n (%) or mean±SD or median (IQR).

  • ACEI/ARB, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers; GRACE, Global Registry for Acute Coronary Events; LVEF, left ventricular ejection fraction; NA, not applicable; PCI, percutaneous coronary intervention.